Overview
- The facility will occupy 44,000 square feet across the first two floors of 2300 Market Street in Center City.
- Lilly plans to host six to eight early-stage biotechs, with initial residents targeted for the first quarter of 2026.
- The Philadelphia site becomes Gateway Labs’ fifth U.S. location, joining Boston, San Diego and two sites in South San Francisco.
- Startups will get fully equipped, move-in-ready wet labs, on-site staffing and programming, and engagement with Breakthrough’s Scientific Advisory Board and Lilly experts.
- Lilly reports Gateway Labs companies have raised more than $3 billion since 2019, and it is interviewing candidates to lead the new site with strong local ties and drug development experience.